相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015
Angela A. Cleveland et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015
Julia Warner Gargano et al.
CLINICAL INFECTIOUS DISEASES (2019)
Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016
Nancy M. McClung et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia
Michaela T. Hall et al.
PLOS ONE (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012
Meg Watson et al.
PREVENTIVE MEDICINE (2017)
National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey
Meg Watson et al.
PREVENTIVE MEDICINE (2017)
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era
Vicki B. Benard et al.
JAMA ONCOLOGY (2017)
Population-Based Trends in High-Grade Cervical Lesions in the Early Human Papillomavirus Vaccine Era in the United States
Susan Hariri et al.
CANCER (2015)
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance
Meg Watson et al.
CANCER CAUSES & CONTROL (2015)
Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening Interim Clinical Guidance
Warner K. Huh et al.
OBSTETRICS AND GYNECOLOGY (2015)
Human papillomavirus testing 2007-2012: Co-testing and triage utilization and impact on subsequent clinical management
Jack Cuzick et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Practice Patterns in Cervical Cancer Screening and Human Papillomavirus Testing
Amanda D. Tatsas et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Mark Schiffman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Trends of Human Papillomavirus Testing in Cervical Cancer Screening at a Large Academic Cytology Laboratory
Darcy F. Phelan et al.
OBSTETRICS AND GYNECOLOGY (2011)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: A systematic review and meta-analysis of non-randomized studies
George Koliopoulos et al.
GYNECOLOGIC ONCOLOGY (2007)
2001 consensus guidelines for the management of women with cervical cytological abnormalities
TC Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
